ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
前日終値
$230.05
+$3.32 · +1.46%
時間外
$230.05
$0.00 · 0.00%
10月9日 18:20 ET
日中の時刻はETです。市場データは遅延する場合があります。
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
日中レンジ
現在 $230.05
52週レンジ
現在 $230.05
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
99
大幅な割安
センチメント
72
強気
リスク
43
やや高いリスク
モメンタム
40
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
日中レンジ
現在 $230.05
52週レンジ
現在 $230.05
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2026年度 | 2025年度 | 2024年度 | 2023年度 | 2022年度 |
|---|---|---|---|---|---|
| 売上高 | 56.53億 USD | 51.46億 USD | 46.85億 USD | 42.23億 USD | 35.78億 USD |
| 売上原価 | 22.02億 USD | 20.91億 USD | 20.3億 USD | 18.67億 USD | 15.54億 USD |
| 粗利益 | 34.52億 USD | 30.55億 USD | 26.55億 USD | 23.56億 USD | 20.24億 USD |
| 研究開発 | 3.78億 USD | 3.31億 USD | 3.08億 USD | 2.88億 USD | 2.54億 USD |
| 販売・一般管理 | 11.2億 USD | 9.91億 USD | 9.17億 USD | 8.74億 USD | 7.39億 USD |
| 営業費用 | 15.43億 USD | 13.7億 USD | 13.35億 USD | 12.24億 USD | 10.24億 USD |
| 支払利息 | — | 1260.9万 USD | 4570.8万 USD | 4737.9万 USD | 2231.2万 USD |
| 減価償却費と償却費 | 2.44億 USD | 2.36億 USD | 2.16億 USD | 1.98億 USD | 1.94億 USD |
| 営業利益 | 19.08億 USD | 16.85億 USD | 13.2億 USD | 11.32億 USD | 10億 USD |
| 純利益 | 15.23億 USD | 14.01億 USD | 10.21億 USD | 8.98億 USD | 7.79億 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$242.7
上昇余地(5.50%)分割調整後の1株当たりの年間現金分配金。
$2.26
2025年(通年)+39.5% 以来 2021
2026年(一部):$1.86
$1.62
2,021
$1.72
2,022
$1.84
2,023
$2.02
2,024
$2.26
2,025
$1.86
2,026*
* 利用可能な配当履歴のうち、暦年の一部のみを含みます。
| 種別 | 配当落ち日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
配当 | 2026年8月20日 | $0.66Quarterly | 2026年8月20日 | 2026年9月24日 |
配当 | 2026年5月14日 | $0.60Quarterly | 2026年5月14日 | 2026年6月18日 |
配当 | 2026年2月12日 | $0.60Quarterly | 2026年2月12日 | 2026年3月19日 |
配当 | 2025年11月13日 | $0.60Quarterly | 2025年11月13日 | 2025年12月18日 |
配当 | 2025年8月14日 | $0.60Quarterly | 2025年8月14日 | 2025年9月18日 |
配当 | 2025年5月8日 | $0.53Quarterly | 2025年5月8日 | 2025年6月12日 |
配当落ち 2026年8月20日
$0.66
Quarterly
2026年8月20日基準 · 支払日 2026年9月24日
配当落ち 2026年5月14日
$0.60
Quarterly
2026年5月14日基準 · 支払日 2026年6月18日
配当落ち 2026年2月12日
$0.60
Quarterly
2026年2月12日基準 · 支払日 2026年3月19日
配当落ち 2025年11月13日
$0.60
Quarterly
2025年11月13日基準 · 支払日 2025年12月18日
配当落ち 2025年8月14日
$0.60
Quarterly
2025年8月14日基準 · 支払日 2025年9月18日
配当落ち 2025年5月8日
$0.53
Quarterly
2025年5月8日基準 · 支払日 2025年6月12日
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。